You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

CLINICAL TRIALS PROFILE FOR SHR0302


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for SHR0302

Trial ID Title Status Sponsor Phase Summary
NCT02423538 ↗ First-in-Human Single Ascending Dose of SHR0302 Unknown status Jiangsu HengRui Medicine Co., Ltd. Phase 1 The purpose of the study is to evaluate the safety and tolerability of single ascending (SAD) oral doses of SHR0302 compared to placebo. Also, pharmacokinetics (PK) and pharmacodynamics (PD) of SHR0302 after single oral administration will be evaluated, and, if applicable, the maximum tolerated dose determined.
NCT02665910 ↗ Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients Unknown status Jiangsu HengRui Medicine Co., Ltd. Phase 1 Condition: Rheumatoid Arthritis Intervention: Drug: SHR0302; Drug: SHR0302 placebo comparator Phase: Phase 1 Study Type: Interventional Study Design: Treatment, Parallel Assignment, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Randomized
NCT02892370 ↗ Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects Unknown status Jiangsu HengRui Medicine Co., Ltd. Phase 1 The purpose of this open-label, randomized, two-period, two-treatment (single doses of 10 mg SHR0302 fasted or fed), crossover study was to evaluate the effect of a high-fat meal on the pharmacokinetics of SHR0302 and mass balance study in 14 healthy subjects.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for SHR0302

Condition Name

Condition Name for
Intervention Trials
Rheumatoid Arthritis 6
Atopic Dermatitis 3
Alopecia Areata 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Arthritis 8
Arthritis, Rheumatoid 7
Dermatitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SHR0302

Trials by Country

Trials by Country for
Location Trials
China 118
United States 28
Canada 4
Ukraine 3
Australia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Florida 4
Oklahoma 3
Texas 2
Tennessee 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SHR0302

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 6
Phase 2/Phase 3 3
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Recruiting 10
Not yet recruiting 5
Completed 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SHR0302

Sponsor Name

Sponsor Name for
Sponsor Trials
Jiangsu HengRui Medicine Co., Ltd. 13
Reistone Biopharma Company Limited 9
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 22
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.